CATX

AMEXStock

Perspective Therapeutics, Inc.

$4.95-0.16 (-3.13%)

52-Week Range

$1.71
$5.65

Key Stats

Market Cap

367.9M

P/E Ratio

Dividend Yield

Beta

1.80

Volume

847.6K

Avg Volume

1.6M

Performance

1M

+8.72%

3M

+101.18%

6M

+56.27%

YTD

+83.15%

1Y

+96.54%

3Y

-2.81%

5Y

+34.47%

Price Chart

ETF Exposure

CATX is held by 42 ETFs

ETFFund NameWeight
IWCiShares Micro-Cap ETF0.07%
IBBiShares Biotechnology ETF0.04%
RFLRInnovator U.S. Small Cap Managed Floor ETF0.04%
IWNiShares Russell 2000 Value ETF0.02%
VTWVVanguard Russell 2000 Value ETF0.01%
IWMiShares Russell 2000 ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.01%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.01%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.01%
SC0K.DEInvesco Russell 2000 UCITS ETF0.01%
R2SC.LState Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)0.01%
RESMColumbia Research Enhanced Small Cap ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
UWMProShares - Ultra Russell20000.01%
VTWOVanguard Russell 2000 ETF0.01%
DFASDimensional - US Small Cap ETF0.01%
URTYProShares - UltraPro Russell20000.01%
AVSCAvantis U.S. Small Cap Equity ETF0.01%
VHTVanguard Health Care ETF0.00%
VXFVanguard Extended Market ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
IWViShares Russell 3000 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About CATX ETF Exposure

Perspective Therapeutics, Inc. (CATX) is held by 42 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 367.9M, CATX is a widely held institutional stock. The stock currently trades at $4.95. Investors can gain exposure to CATX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CATX, sorted by portfolio weight.